Tsimafeyeu, I., Lebedinets, A., Murzalina, M., Zhuravlev, A., Peryshkina, V., Mukhitova, M., Bulychkin, P. V. (2026). A randomized phase 2 trial of lenvatinib plus pembrolizumab with or without stereotactic body radiotherapy in patients with metastatic renal cell carcinoma, low tumor burden, and stable disease (LASER).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps583